Research

Milestones

 

  • ASCO/FDA Fellow’s Clinical Workshop. November, 2020. Silver Springs, MD-Akshjot Puri, M.D.
  • ICML International Conference of Malignant Lymphoma (Switzerland):
    • Kartik Anand M.D.: Comprehensive report of anti-CD19 chimeric antigen receptor T-cells (CAR-T) associated Non Relapse Mortality (CART-NRM) from FAERS
  • ASCO 2019
    • Emre Koca M.D.: Phase II Trial Of Neoadjuvant TAK-228 Plus Tamoxifen In Patients With (ER)-Positive, HER2-Negative Breast Cancer. MERIT AWARD
    • Kartik Anand M.D.: Comprehensive report of anti-CD19 chimeric antigen receptor T cells (CAR-T) associated non-relapse mortality (CART-NRM) from FAERS. MERIT AWARD
    • Kartik Anand M.D. Neoadjuvant Phase II study of Everolimus plus Cisplatin in TNBC patients with Residual Disease
  • ASCO-SITC (Society of Immunotherapy of Cancer) 2019
    • Kartik Anand M.D.: T-cell lymphoma secondary to CPI use for other malignancies. MERIT AWARD
  • Houston Methodist Cancer Symposium 2018
    • Sarah Creamer M.D.: Best clinical Trial Poster Award
  • Texas ASCO 2018
    • Emre Koca M.D.: Association of PRAME expression with clinical features in uveal melanoma ($1000 Award)
  • ICML International Conference of Malignant Lymphoma (Switzerland):XXXX
    • Kartik Anand, M.D.: Comprehensive report of anti-CD19 chimeric antigen receptor T-cells (CAR-T) associated Non Relapse Mortality (CART-NRM) from FAERS
  • ASCO 2019
    • Emre Koca, M.D.: Open Label, Phase II Trial Of Neoadjuvant TAK-228 Plus Tamoxifen In Patients With Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Receptor Type 2 (HER2)-Negative Breast Cancer. MERIT AWARD
    • Kartik Anand, M.D.: Comprehensive report of anti-CD19 chimeric antigen receptor T cells (CAR-T) associated non-relapse mortality (CART-NRM) from FAERS.  MERIT AWARD
    • Kartik Anand, M.D.: Neoadjuvant Phase II study of Everolimus plus Cisplatin in Triple Negative Breast Cancer (TNBC) patients with Residual Disease
  • ASCO-SITC 2019
    • Kartik Anand, M.D.: T-cell lymphoma secondary to CPI use for other malignancies. MERIT AWARD
  • Texas ASCO 2019
    • Emre Koca, M.D. $1,000 MERIT AWARD: Anett study of neoadjuvant mtor inhibitor with tamoxifen in estrogen receptor positive breast cancer patients.
    • Usman Khan, M.D. $1,000 MERIT AWAR: Comparison of efficacy and side effects of weekly vs. dose dense Paclitaxel in breast cancer: A meta-analysis
    • Akshjot Puri, M.D. $500 MERIT AWARD: An association with CD 30 positive lymphomas.
    • Cesar Gentille, M.D. $500 MERIT AWARD: Use of Radiation Therapy in Primary Mediastinal Large B-Cell Lymphoma (PMLBCL) Treated With DA-R-EPOCH.

 

 

2019 ASCO Vail Recipients

 

  • Emre Koca M.D. Phase I study of autologous T lymphocytes expressing GD2-specific chimeric antigen treatment of patients with pre-treated metastatic uveal melanoma patients.
  • Akshjot Puri M.D. Neurocognitive and Neuroimaging Assessments in Investigating the Mechanism of Cancer-Related Cognitive Impairment in Breast Cancer

 

 

Publications To Date

 

  1. Guerrero C, Jain T, Kelemen K. HHV-8-Associated Lymphoproliferative Disorders and Pathogenesis in an HIV-Positive Patient.
    Case Rep Hematol. 2019;2019:4536157. Published 2019 Aug 22. doi:10.1155/2019/4536157
  2. Puri A, Reddy T, Patel TA, Chang JC. Metastatic triple negative breast cancer: Established and Emerging Treatments. The breast journal. In Press
  3. Puri A, Kamble RT, Pingali SR. Individualizing Approach to Primary CNS Lymphoma. Diagnosis and Treatment: Hematology journal. In Press
  4. Kai Sun, Ryan J Reynolds, Tiffany G Sheu, Jessica A Thomsula, Laura Colton, Lawrence Rice. Acute myeloid leukemia presenting as acute liver failure- a case report and literature review.
    Ecancermedicalscience. 2019 Sep 9; 13:960. https://doi.org /10.3332/ecancer.2019.960. Pubmed ID: 31645888
  5. Gentille C, Anand K, Dalwadi S, Puri A, Farach A, Pingali S. Radiation therapy in primary mediastinal large B‐cell lymphoma treated with DA‐R‐EPOCH.
    Clinical case reports. 2020 April; doi: https://doi.org/10.1002/ccr3.2853.
  6. Kasparian S, Gentille C, Burns E, Bernicker EH. Hyperprogressive non-small cell lung cancer with two immune-checkpoint inhibitors.
    JTO Clinical and Research Reports. 2020 February; doi: https://doi.org/10.1016/j.jtocrr.2020.100017
  7. Burns EA, Gentille C, Kasparian S, Pingali SR. A Case of Histiocytic Sarcoma Arising from Mycosis Fungoides.
    Case Rep Hematol. 2019;2019:7834728. doi: 10.1155/2019/7834728. eCollection 2019. PubMed PMID: 31687231; PubMed Central PMCID: PMC6794960
  8. Schefler A, Koca E, Bernicker E, Correa Z. Relationship between clinical features, GEP class and PRAME expression in uveal melanoma.  Graefe’s Archive for clinical and experimental opthomology. 2019; 1-5.
  9. Anand K, Kumar P, Pingali SR et al. Acute myeloid leukemia with eosinophilia after cyclin-dependent kinases 4/6 inhibitor treatment due to underlying clonal hematopoiesis of indeerminate potential. Am J Hematol 2019; 94: E82-E85.
  10. Anand K, Niravath P. Acupuncture and Vitamin D for the Management of Aromatase Inhibitor-Induced Arthralgia. Curr Oncol Rep 2019; 21: 51.
  11. Anand K, Ibrahim I. Four Limb Ischemia: A Severe Case of Heparin Induced Thrombocytopenia. Indian J Hematol Blood Transfus 2019; 35: 397-398.
  12. Burns E, Anand K, Acosta G et al. Autosplenectomy in a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH). Case Rep Hematol 2019; 2019: 3146965.
  13. Wallis CJ, Satkunasivam R, Butaney M, Khan UA, Goldberg HA..Klaassen et al. Association between smoking and survival benefit of immunotherapy in advanced malignancies: A systemic review and meta-analysis. American Journal of Cliniacl Oncology 2019 September; 42(9): 711-716
  14. Patel, TA, Ensor JE, Creamer SL, Boone T..Chang JC. A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2 positive breast cancer (TEAL study). Breast cancer research 2019 Sept 2; 21(1):100
  15. Kasparian S, Anand K, Burns E, Chung B, Pingali SRK. Macrophage Activation Syndrome Secondary to Underlying Sarcoidosis. 2019 Jun 18; 11(6)
  16. Anand K, Roszik J, Hall C…Patel S. Pilot Study of Circulating Tumor cells in Early Stage and Metastatic Uveal Melanoma. Cancers (Basel). 2019 Jun 20; 11(6)
  17. Anand K, Pingali SR, Trachtenberg B, Iyer SP. Complete Response to R-EPOCH in Primary Cardiac Lymphoma. Case R Hematology 2019 April 10.
  18. Anand, K, Ibrahim I. Four Lim Ischemia: A severe case of Heparin Induced Thrombocytopenia.  Indian J Hematology Blood Transfusion 2019 April